{"product_id":"9783319974200","title":"Cardiac Extracellular Matrix Fundamental Science to Clinical Applications","description":"\u003ch3\u003eAdvances in Experimental Medicine and Biology\u003c\/h3\u003e\u003ch1\u003eCardiac Extracellular Matrix\u003c\/h1\u003e\u003ch2\u003eFundamental Science to Clinical Applications\u003c\/h2\u003e\u003ch3\u003eEric G. Schmuck | Peiman Hematti | Amish N. Raval\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Life Sciences \/ Cell Biology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eComprehensively discusses recent discoveries in the field\u003cdiv\u003ePresents novel experimental approaches to developing potential therapies, including implications for Regenerative Medicine\u003c\/div\u003e\n\u003cdiv\u003eSection on Clinical Applications highlights therapeutic strategies, clinical trial design, current human trials and the role of pharma and biotech companies\u003c\/div\u003e\n\u003cdiv\u003eEssential reading for those in research, clinical practice, or industry \u003c\/div\u003e\n\u003c\/div\u003e\u003cdiv\u003e\n\u003cb\u003e​Eric Schmuck, PhD\u003c\/b\u003e, is a Senior Scientist with the Division of Cardiovascular Medicine at the University of Wisconsin-Madison School of Medicine and Public Health where he leads multi-disciplinary research teams focused on bringing regenerative medicine therapies to the clinic. He received his PhD in Human Physiology from the University of Wisconsin-Madison and is an expert in cardiac extracellular matrix and translational research models, specifically focusing on cardiac regeneration. His major research interests are in cardiac extracellular matrix, bioengineering and regenerative medicine therapies for the heart.  He has authored numerous peer-reviewed manuscripts and book chapters in the regenerative medicine field and holds multiple patents on cardiac extracellular matrix technologies. Finally, he is a co-founder and Chief Scientific Officer of Cellular Logistics Inc., a biotech company developing innovative biomaterial solutions to enhance stem cell retention for the treatment of advanced cardiovascular disease.\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cb\u003ePeiman Hematti, MD\u003c\/b\u003e is Professor of Medicine in section of Hematology\/Oncology, UW-Madison School of Medicine and Public Health, with joint appointments in departments of pediatrics, surgery and biomedical engineering. He is director of Clinical Hematopoietic Cell Processing Laboratory, and medical director of Apheresis and Hematopoietic Cell Collection facility at University of Wisconsin-Madison. As a bone marrow stem cell transplant physician, his major clinical research interest is in immunology of transplantation and use of novel cellular therapies for malignant and non-malignant disorders, including use of bone marrow stem cells in cardiovascular medicine. His current laboratory research focuses on immunobiology of stem cell transplantation with a special focus on investigating the immunomodulatory and anti-inflammatory properties of macrophages, including their interactions with biomaterials used in regenerative medicine. He has been a co-author in more than 100 peer-reviewed manuscripts, 10 book chapters, and has been co-editor of two other books in the field of stem cells and regenerative medicine.  He has been inventor of several patents issued and filed in the field of cellular therapy and regenerative medicine. He is a co-founder and chair of the Scientific Advisory Board for Cellular Logistics Inc.\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cb\u003eAmish N. Raval MD\u003c\/b\u003e is an Associate Professor of Medicine and Biomedical Engineering at the University of Wisconsin. He received his MD at the U. of Western Ontario, where he completed Internal Medicine and Cardiology Residency.  He subsequently completed his Interventional Cardiology Fellowship at Georgetown University\/Washington Hospital Center, and later, he joined the National Heart, Lung and Blood Institute, Bethesda.  Thereafter, he became a Faculty member at the University of Wisconsin School of Medicine and Public Health where he is Di^12 cardiovascular regenerative medicine clinical trials ranging from Phase 1 to 3. He has served as a scientific advisor for several biotech companies and is Chairman of the Board for Cellular Logistics Inc, which is a biotech company that is developing innovative biomaterial solutions to enhance stem cell retention for the treatment of advanced cardiovascular disease.\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e04 October 2018\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eSpringer Nature Switzerland\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eSpringer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9783319974200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e246\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Springer Nature Switzerland","offers":[{"title":"Default Title","offer_id":46265520193676,"sku":"9783319974200","price":161.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783319974200.jpg?v=1780592708","url":"https:\/\/fh90cf-fv.myshopify.com\/products\/9783319974200","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}